(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors

Eur J Med Chem. 2015 Jun 15:98:49-53. doi: 10.1016/j.ejmech.2015.05.019. Epub 2015 May 16.

Abstract

A novel class of potent FXIII-A inhibitors containing a (±) cis-bisamido epoxide pharmacophore is described. The compounds display highly potent inhibition of FXIII-A (IC50 = 5-500 nM) in an in vitro assay. In contrast to other types of previously described covalent transglutaminase inhibitors, the bis-amido epoxides exhibited no measurable reactivity with glutathione, therefore possibly rendering this class of compounds suitable for future in vivo investigations. Additionally, the compounds show selective inhibition for FXIII-A against the cysteine protease, cathepsin S although they proved to have similar potency with a closely related transglutaminase, TGII, to that observed for FXIII-A.

Keywords: Bis-amido epoxides molecular modelling; FXIII-A; Thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Evaluation, Preclinical
  • Epoxy Compounds / chemistry
  • Epoxy Compounds / pharmacology*
  • Factor XIII / antagonists & inhibitors*
  • Models, Molecular

Substances

  • Epoxy Compounds
  • Factor XIII